{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:35:38Z","timestamp":1788568538943,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"DOI":"10.1007\/s10877-025-01356-1","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T06:58:47Z","timestamp":1757401127000},"page":"501-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Target controlled infusion in the intensive care unit: a scoping review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6574-8605","authenticated-orcid":false,"given":"Michele","family":"Introna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6677-1172","authenticated-orcid":false,"given":"Carla","family":"Carozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4494-7020","authenticated-orcid":false,"given":"Andrea","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccarda","family":"Girasole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-3831","authenticated-orcid":false,"given":"Marco","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-3998","authenticated-orcid":false,"given":"Jeroen V.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-536X","authenticated-orcid":false,"given":"Michel M. R. F.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-714X","authenticated-orcid":false,"given":"Johannes P.","family":"van Den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"1","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/EJA.0000000000000683","volume":"35","author":"J Hinkelbein","year":"2018","unstructured":"Hinkelbein J, Lamperti M, Akeson J, Santos J, Costa J, De Robertis E, et al. European society of anaesthesiology and european board of anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol. 2018;35(1):6\u201324.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1213\/ANE.0000000000001009","volume":"122","author":"AR Absalom","year":"2016","unstructured":"Absalom AR, Glen JIB, Zwart GJC, Schnider TW, Struys MMRF. Target-controlled infusion: a mature technology. Anesth Analg. 2016;122(1):70\u20138.","journal-title":"Anesth Analg"},{"issue":"2","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bja.2020.10.027","volume":"126","author":"R Vellinga","year":"2021","unstructured":"Vellinga R, Hannivoort LN, Introna M, Touw DJ, Absalom AR, Eleveld DJ, et al. Prospective clinical validation of the eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia. Br J Anaesth. 2021;126(2):386\u201394.","journal-title":"Br J Anaesth"},{"issue":"6","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/ALN.0000000000001634","volume":"126","author":"DJ Eleveld","year":"2017","unstructured":"Eleveld DJ, Proost JH, Vereecke H, Absalom AR, Olofsen E, Vuyk J, et al. An allometric model of remifentanil pharmacokinetics and pharmacodynamics. Anesthesiology. 2017;126(6):1005\u201318.","journal-title":"Anesthesiology"},{"issue":"12","key":"1356_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123493","volume":"11","author":"R Vellinga","year":"2022","unstructured":"Vellinga R, Valk BI, Absalom AR, Struys MMRF, Barends CRM. What\u2019s new in intravenous anaesthesia? new hypnotics, new models and new applications. J Clin Med. 2022;11(12):3493 (Jun 17;).","journal-title":"J Clin Med"},{"issue":"1","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"e01552","DOI":"10.1128\/AAC.01552-19","volume":"64","author":"S Jonckheere","year":"2019","unstructured":"Jonckheere S, De Neve N, Verbeke J, De Decker K, Brandt I, Boel A, et al. Target-controlled infusion of cefepime in critically ill patients. Antimicrob Agents Chemother. 2019;64(1):e01552-e1619.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s40262-018-0643-8","volume":"57","author":"PJ Colin","year":"2018","unstructured":"Colin PJ, Jonckheere S, Struys MMRF. Target-controlled continuous infusion for antibiotic dosing: proof-of-principle in an in-silico vancomycin trial in intensive care unit patients. Clin Pharmacokinet. 2018;57(11):1435\u201347.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0310057X1204000412","volume":"40","author":"SY Kim","year":"2012","unstructured":"Kim SY, Yang SY, Na SW, Jo YY, Koh SO. Low-dose remifentanil infusion during ventilator weaning and tracheal extubation in postoperative intensive care unit patients sedated with propofol-remifentanil: a randomised clinical trial. Anaesth Intensive Care. 2012;40(4):656\u201362.","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"1356_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00134-012-2697-7","volume":"39","author":"L Chalumeau-Lemoine","year":"2013","unstructured":"Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F. Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med. 2013;39(1):53\u20138.","journal-title":"Intensive Care Med"},{"issue":"5","key":"1356_CR10","first-page":"273","volume":"36","author":"S Rezaiguia-Delclaux","year":"2017","unstructured":"Rezaiguia-Delclaux S, Laverdure F, Kortchinsky T, Lemasle L, Imbert A, St\u00e9phan F. Fiber optic bronchoscopy and remifentanil target-controlled infusion in critically ill patients with acute hypoxaemic respiratory failure: a descriptive study. Anaesth Crit Care Pain Med. 2017;36(5):273\u20137.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"1356_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13613-021-00832-6","volume":"11","author":"M Caron","year":"2021","unstructured":"Caron M, Parrot A, Elabbadi A, Dupeyrat S, Turpin M, Baury T, et al. Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion. Ann Intensive Care. 2021;11(1):48.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"1356_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10877-023-01119-w","volume":"38","author":"A Joosten","year":"2024","unstructured":"Joosten A, Rinehart J, Cannesson M, Coeckelenbergh S, Pochard J, Vicaut E, et al. Control of mean arterial pressure using a closed-loop system for norepinephrine infusion in severe brain injury patients: the COMAT randomized controlled trial. J Clin Monit Comput. 2024;38(1):25\u201330.","journal-title":"J Clin Monit Comput"},{"issue":"1","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10877-023-01104-3","volume":"38","author":"S Coeckelenbergh","year":"2024","unstructured":"Coeckelenbergh S, Soucy-Proulx M, Van der Linden P, Clanet M, Rinehart J, Cannesson M, et al. Tight control of mean arterial pressure using a closed loop system for norepinephrine infusion after high-risk abdominal surgery: a randomized controlled trial. J Clin Monit Comput. 2024;38(1):19\u201324.","journal-title":"J Clin Monit Comput"},{"issue":"5","key":"1356_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1213\/ANE.0000000000005888","volume":"134","author":"O Desebbe","year":"2022","unstructured":"Desebbe O, Rinehart J, Van der Linden P, Cannesson M, Delannoy B, Vigneron M, et al. Control of postoperative hypotension using a closed-loop system for norepinephrine infusion in patients after cardiac surgery: a randomized trial. Anesth Analg. 2022;134(5):964\u201373.","journal-title":"Anesth Analg"},{"issue":"1","key":"1356_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2478\/jccm-2022-0001","volume":"8","author":"J Szederjesi","year":"2022","unstructured":"Szederjesi J. Target controlled infusion: an anaesthetic technique brought in ICU. The Journal of Critical Care Medicine. 2022;8(1):3\u20135.","journal-title":"The Journal of Critical Care Medicine"},{"issue":"Nov 20","key":"1356_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","volume":"77","author":"SI Blot","year":"2014","unstructured":"Blot SI, Pea F, Lipman J. The effect of pathophysiology on pharmacokinetics in the critically ill patient \u2014 concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014;77(Nov 20):3\u201311.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00000542-200308000-00023","volume":"99","author":"KB Johnson","year":"2003","unstructured":"Johnson KB, Egan TD, Kern SE, White JL, McJames SW, Syroid N, et al. The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology. 2003;99(2):409\u201320.","journal-title":"Anesthesiology"},{"issue":"3","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/00000542-200409000-00013","volume":"101","author":"KB Johnson","year":"2004","unstructured":"Johnson KB, Egan TD, Kern SE, McJames SW, Cluff ML, Pace NL. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology. 2004;101(3):647\u201359.","journal-title":"Anesthesiology"},{"issue":"2","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00000542-200102000-00023","volume":"94","author":"KB Johnson","year":"2001","unstructured":"Johnson KB, Kern SE, Hamber EA, McJames SW, Kohnstamm KM, Egan TD. Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology. 2001;94(2):322\u201332.","journal-title":"Anesthesiology"},{"issue":"2","key":"1356_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1378\/chest.114.2.541","volume":"114","author":"MH Kollef","year":"1998","unstructured":"Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114(2):541\u20138.","journal-title":"Chest"},{"issue":"8","key":"1356_CR21","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s001340101017","volume":"27","author":"MJ Dubois","year":"2001","unstructured":"Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001;27(8):1297\u2013304.","journal-title":"Intensive Care Med"},{"issue":"14","key":"1356_CR22","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1056\/NEJMoa1301372","volume":"369","author":"PP Pandharipande","year":"2013","unstructured":"Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306\u201316.","journal-title":"N Engl J Med"},{"key":"1356_CR23","doi-asserted-by":"crossref","unstructured":"Rock LF. Sedation and its association with posttraumatic stress disorder after intensive care. Crit Care Nurse. 2014 Feb;34(1):30\u20137; quiz 39.","DOI":"10.4037\/ccn2014209"},{"issue":"8","key":"1356_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, et al. DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072\u201383.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1356_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04098-7","volume":"26","author":"LF Roggeveen","year":"2022","unstructured":"Roggeveen LF, Guo T, Fleuren LM, Driessen R, Thoral P, van Hest RM, et al. Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial. Crit Care. 2022;26(1):265.","journal-title":"Crit Care"},{"key":"1356_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/TCRM.S67211","volume":"10","author":"T Kunisawa","year":"2014","unstructured":"Kunisawa T, Fujimoto K, Kurosawa A, Nagashima M, Matsui K, Hayashi D, et al. The dexmedetomidine concentration required after remifentanil anesthesia is three-fold higher than that after fentanyl anesthesia or that for general sedation in the ICU. Ther Clin Risk Manag. 2014;10:797\u2013806.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"1356_CR27","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/00000542-199812000-00020","volume":"89","author":"K Zomorodi","year":"1998","unstructured":"Zomorodi K, Donner A, Somma J, Barr J, Sladen R, Ramsay J, et al. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology. 1998;89(6):1418\u201329.","journal-title":"Anesthesiology"},{"issue":"4","key":"1356_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10877-018-0208-2","volume":"33","author":"M Neckebroek","year":"2019","unstructured":"Neckebroek M, Ionescu CM, van Amsterdam K, De Smet T, De Baets P, Decruyenaere J, et al. A comparison of propofol-to-BIS post-operative intensive care sedation by means of target controlled infusion, Bayesian-based and predictive control methods: an observational, open-label pilot study. J Clin Monit Comput. 2019;33(4):675\u201386.","journal-title":"J Clin Monit Comput"},{"issue":"7","key":"1356_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1365-2044.2004.03745.x","volume":"59","author":"TJ McMurray","year":"2004","unstructured":"McMurray TJ, Johnston JR, Milligan KR, Grant IS, Mackenzie SJ, Servin F, et al. Propofol sedation using diprifusor target-controlled infusion in adult intensive care unit patients. Anaesthesia. 2004;59(7):636\u201341.","journal-title":"Anaesthesia"},{"issue":"6","key":"1356_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4103\/ijccm.IJCCM_327_17","volume":"22","author":"D Masapu","year":"2018","unstructured":"Masapu D, Gopala Krishna KN, Sanjib S, Chakrabarti D, Mundlamuri RC, Manohar N, et al. A comparative study of midazolam and target-controlled propofol infusion in the treatment of refractory status epilepticus. Indian J Crit Care Med. 2018;22(6):441\u20138.","journal-title":"Indian J Crit Care Med"},{"issue":"10","key":"1356_CR31","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00134-010-1904-7","volume":"36","author":"B Clouzeau","year":"2010","unstructured":"Clouzeau B, Bui HN, Vargas F, Grenouillet-Delacre M, Guilhon E, Gruson D, et al. Target-controlled infusion of propofol for sedation in patients with non-invasive ventilation failure due to low tolerance: a preliminary study. Intensive Care Med. 2010;36(10):1675\u201380.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1356_CR32","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00134-011-2375-1","volume":"37","author":"B Clouzeau","year":"2011","unstructured":"Clouzeau B, Bui HN, Guilhon E, Grenouillet-Delacre M, Leger MS, Saghi T, et al. Fiberoptic bronchoscopy under noninvasive ventilation and propofol target-controlled infusion in hypoxemic patients. Intensive Care Med. 2011;37(12):1969\u201375.","journal-title":"Intensive Care Med"},{"issue":"2","key":"1356_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00000542-200108000-00011","volume":"95","author":"J Barr","year":"2001","unstructured":"Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology. 2001;95(2):324\u201333.","journal-title":"Anesthesiology"},{"issue":"4","key":"1356_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/bja\/aei074","volume":"94","author":"F Cavaliere","year":"2005","unstructured":"Cavaliere F, Conti G, Moscato U, Meo F, Pennisi MA, Costa R, et al. Hypoalbuminaemia does not impair diprifusor performance during sedation with propofol. Br J Anaesth. 2005;94(4):453\u20138.","journal-title":"Br J Anaesth"},{"issue":"5","key":"1356_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/jcph.1060","volume":"58","author":"A Cortegiani","year":"2018","unstructured":"Cortegiani A, Pavan A, Azzeri F, Accurso G, Vitale F, Gregoretti C. Precision and bias of target-controlled prolonged propofol infusion for general anesthesia and sedation in neurosurgical patients. J Clin Pharmacol. 2018;58(5):606\u201312.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"1356_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/bja\/67.1.41","volume":"67","author":"B Marsh","year":"1991","unstructured":"Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth. 1991;67(1):41\u20138.","journal-title":"Br J Anaesth"},{"issue":"9","key":"1356_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092487","volume":"11","author":"O Van demoortele","year":"2022","unstructured":"Van demoortele O, Hannivoort LN, Van hoorebeeck F, Struys MMRF, Vereecke HEM. General purpose pharmacokinetic-pharmacodynamic models for target-controlled infusion of anaesthetic drugs: a narrative review. J Clin Med. 2022;11(9):2487.","journal-title":"J Clin Med"},{"issue":"5","key":"1356_CR38","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/00000542-199805000-00006","volume":"88","author":"TW Schnider","year":"1998","unstructured":"Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88(5):1170\u201382.","journal-title":"Anesthesiology"},{"issue":"5","key":"1356_CR39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.bja.2018.01.018","volume":"120","author":"DJ Eleveld","year":"2018","unstructured":"Eleveld DJ, Colin P, Absalom AR, Struys MMRF. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth. 2018;120(5):942\u201359.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1356_CR40","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/j.bja.2019.10.019","volume":"124","author":"T H\u00fcppe","year":"2020","unstructured":"H\u00fcppe T, Maurer F, Sessler DI, Volk T, Kreuer S. Retrospective comparison of eleveld, Marsh, and Schnider propofol pharmacokinetic models in 50 patients. Br J Anaesth. 2020;124(2):e22\u20134.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1356_CR41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1213\/ANE.0000000000005125","volume":"132","author":"TW Schnider","year":"2021","unstructured":"Schnider TW, Minto CF, Egan TD, Filipovic M. Relationship between propofol target concentrations, bispectral index, and patient covariates during anesthesia. Anesth Analg. 2021;132(3):735\u201342.","journal-title":"Anesth Analg"},{"issue":"5","key":"1356_CR42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/bja\/88.5.669","volume":"88","author":"RM Venn","year":"2002","unstructured":"Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth. 2002;88(5):669\u201375.","journal-title":"Br J Anaesth"},{"issue":"5","key":"1356_CR43","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00000542-199305000-00003","volume":"78","author":"JB Dyck","year":"1993","unstructured":"Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78(5):821\u20138.","journal-title":"Anesthesiology"},{"issue":"1","key":"1356_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00540-017-2424-1","volume":"32","author":"S Obara","year":"2018","unstructured":"Obara S, Imaizumi T, Hakozaki T, Hosono A, Iseki Y, Sanbe N, et al. Evaluation of pharmacokinetic models of intravenous dexmedetomidine in sedated patients under spinal anesthesia. J Anesth. 2018;32(1):33\u201340.","journal-title":"J Anesth"},{"issue":"2","key":"1356_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/ALN.0000000000000740","volume":"123","author":"LN Hannivoort","year":"2015","unstructured":"Hannivoort LN, Eleveld DJ, Proost JH, Reyntjens KMEM, Absalom AR, Vereecke HEM, et al. Development of an optimized pharmacokinetic model of Dexmedetomidine using target-controlled infusion in healthy volunteers. Anesthesiology. 2015;123(2):357\u201367.","journal-title":"Anesthesiology"},{"issue":"4","key":"1356_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/jcan.2000.7931","volume":"14","author":"L Barvais","year":"2000","unstructured":"Barvais L, Heitz D, Schmartz D, Maes V, Coussaert E, Cantraine F, et al. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: assessment of the prospective predictive accuracy and the quality of anesthesia. J Cardiothorac Vasc Anesth. 2000;14(4):402\u20138.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"1356_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/clpt.1990.192","volume":"48","author":"M B\u00fchrer","year":"1990","unstructured":"B\u00fchrer M, Maitre PO, Crevoisier C, Stanski DR. Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther. 1990;48(5):555\u201367.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1356_CR48","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/bcp.16031","volume":"90","author":"TG van Gelder","year":"2024","unstructured":"van Gelder TG, van Diem-Zaal IJ, Dijkstra-Kersten SMA, de Mul N, Lalmohamed A, Slooter AJC. The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. Br J Clin Pharmacol. 2024;90(6):1471\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1356_CR49","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bja.2020.05.051","volume":"125","author":"DJ Eleveld","year":"2020","unstructured":"Eleveld DJ, Colin P, Absalom AR, Struys MMRF. Target-controlled-infusion models for remifentanil dosing consistent with approved recommendations. Br J Anaesth. 2020;125(4):483\u201391.","journal-title":"Br J Anaesth"},{"issue":"1","key":"1356_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00000542-199701000-00005","volume":"86","author":"CF Minto","year":"1997","unstructured":"Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997;86(1):24\u201333.","journal-title":"Anesthesiology"},{"issue":"2","key":"1356_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/11317690-000000000-00000","volume":"49","author":"L La Colla","year":"2010","unstructured":"La Colla L, Albertin A, La Colla G, Porta A, Aldegheri G, Di Candia D, et al. Predictive performance of the \u201cMinto\u201d remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass. Clin Pharmacokinet. 2010;49(2):131\u20139.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1356_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bja.2022.05.003","volume":"129","author":"V Scherrer","year":"2022","unstructured":"Scherrer V, Lamoureux F, Chaventre C, Thill C, Demailly Z, Selim J, et al. Reliability of the minto model for target-controlled infusion of remifentanil during cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2022;129(2):163\u201371.","journal-title":"Br J Anaesth"},{"issue":"6","key":"1356_CR53","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/ALN.0000000000001635","volume":"126","author":"TK Kim","year":"2017","unstructured":"Kim TK, Obara S, Egan TD, Minto CF, La Colla L, Drover DR, et al. Disposition of remifentanil in obesity: a new pharmacokinetic model incorporating the influence of body mass. Anesthesiology. 2017;126(6):1019\u201332.","journal-title":"Anesthesiology"},{"issue":"6","key":"1356_CR54","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/00000542-199512000-00010","volume":"83","author":"E Gepts","year":"1995","unstructured":"Gepts E, Shafer SL, Camu F, Stanski DR, Woestenborghs R, Van Peer A, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology. 1995;83(6):1194\u2013204.","journal-title":"Anesthesiology"},{"issue":"6","key":"1356_CR55","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/00000542-199012000-00005","volume":"73","author":"SL Shafer","year":"1990","unstructured":"Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology. 1990;73(6):1091\u2013102.","journal-title":"Anesthesiology"},{"issue":"2","key":"1356_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1751143714564816","volume":"16","author":"S Shah","year":"2015","unstructured":"Shah S, Barton G, Fischer A. Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient. J Intensive Care Soc. 2015;16(2):147\u201353.","journal-title":"J Intensive Care Soc"},{"issue":"11","key":"1356_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1356_CR58","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00134-013-3088-4","volume":"39","author":"AA Udy","year":"2013","unstructured":"Udy AA, Roberts JA, Lipman J. Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med. 2013;39(12):2070\u201382.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1356_CR59","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Aziz MHA, Lipman J, Mouton JW, Vinks AA, Felton TW, et al. Challenges and potential solutions \u2013 individualised antibiotic dosing at the bedside for critically ill patients: a structured review. Lancet Infect Dis. 2014;14(6):498\u2013509.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1356_CR60","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/1440-1681.13597","volume":"49","author":"JY Bang","year":"2022","unstructured":"Bang JY, Kang HI, Lee HJ, Chong YP, Hong SK, Lee EK, et al. Development of a new pharmacokinetic model for target-concentration controlled infusion of vancomycin in critically ill patients. Clin Exp Pharmacol Physiol. 2022;49(2):202\u201311.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"1356_CR61","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bja.2022.12.026","volume":"130","author":"D Hight","year":"2023","unstructured":"Hight D, Kreuzer M, Ugen G, Schuller P, St\u00fcber F, Sleigh J, et al. Five commercial depth of anaesthesia monitors provide discordant clinical recommendations in response to identical emergence-like EEG signals. Br J Anaesth. 2023;130(5):536\u201345.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1356_CR62","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10877-023-01004-6","volume":"37","author":"M Introna","year":"2023","unstructured":"Introna M, Gemma M, Carozzi C. Improving the benefit of processed EEG monitors: it\u2019s not about the car but the driver. J Clin Monit Comput. 2023;37(3):723\u20135.","journal-title":"J Clin Monit Comput"},{"issue":"2","key":"1356_CR63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12028-022-01565-5","volume":"38","author":"FA Rasulo","year":"2023","unstructured":"Rasulo FA, Hopkins P, Lobo FA, Pandin P, Matta B, Carozzi C, et al. Processed electroencephalogram-based monitoring to guide sedation in critically ill adult patients: recommendations from an international expert panel-based consensus. Neurocrit Care. 2023;38(2):296\u2013311.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1356_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10877-022-00905-2","volume":"37","author":"FA Lobo","year":"2023","unstructured":"Lobo FA, Robba C, Lamperti M, Romagnoli S, Rasulo FA. Processed EEG monitoring in critical care: a black swan or a shining star? J Clin Monit Comput. 2023;37(1):3\u20135.","journal-title":"J Clin Monit Comput"},{"issue":"4","key":"1356_CR65","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1213\/ANE.0000000000007042","volume":"140","author":"T Kinateder","year":"2025","unstructured":"Kinateder T, Kratzer S, Husemann C, Hautmann H, Garc\u00eda PS, Schneider G, et al. Electroencephalogram-based anesthesia indices differently react to modulations of alpha-oscillatory activity. Anesth Analg. 2025;140(4):974\u201382.","journal-title":"Anesth Analg"},{"issue":"3","key":"1356_CR66","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/ALN.0000000000005315","volume":"142","author":"RV Mather","year":"2025","unstructured":"Mather RV, Nipp R, Balanza G, Stone TAD, Gutierrez R, Raje P, et al. Intraoperative frontal electroencephalogram alpha power is associated with postoperative mortality and other adverse outcomes. Anesthesiology. 2025;142(3):500\u201310.","journal-title":"Anesthesiology"},{"issue":"4","key":"1356_CR67","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10877-025-01294-y","volume":"39","author":"S Schwerin","year":"2025","unstructured":"Schwerin S, Dragovic SZ, Ostertag J, Nguyen DM, Schneider G, Kreuzer M. EEG features associated with Alzheimer\u2019s disease and frontotemporal dementia are not reflected by processed indices used in anesthesia monitoring. J Clin Monit Comput. 2025;39(4):681\u201396.","journal-title":"J Clin Monit Comput"},{"issue":"8","key":"1356_CR68","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1023\/A:1012216600170","volume":"16","author":"J Bruhn","year":"2000","unstructured":"Bruhn J, Bouillon TW, Shafer SL. Bispectral index (BIS) and burst suppression: revealing a part of the BIS algorithm. J Clin Monit Comput. 2000;16(8):593\u20136.","journal-title":"J Clin Monit Comput"},{"issue":"4","key":"1356_CR69","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.bja.2024.11.050","volume":"134","author":"M Ebensperger","year":"2025","unstructured":"Ebensperger M, Kreuzer M, Kratzer S, Schneider G, Schwerin S. Impact of age on the reliability of GE entropy\u2122 module indices for guidance of maintenance of anaesthesia in adult patients: a single-centre retrospective analysis. Br J Anaesth. 2025;134(4):1077\u201387.","journal-title":"Br J Anaesth"},{"issue":"6","key":"1356_CR70","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.bja.2022.08.026","volume":"129","author":"A Abad- Torrent","year":"2022","unstructured":"Abad-Torrent A, Mart\u00ednez-V\u00e1zquez P, Somma J, Hsu YW, Izquierdo E. Remifentanil pharmacodynamics during conscious sedation using algometry: a more clinically relevant pharmacodynamical model. Br J Anaesth. 2022;129(6):868\u201378.","journal-title":"Br J Anaesth"},{"key":"1356_CR71","doi-asserted-by":"publisher","unstructured":"Gentile A, Introna M. Interpreting heart rate variability: addressing the role of anesthesia and pain. J Clin Monit Comput [Internet]. 2025 Jun 6 [cited 2025 Jun 17]; Available from: https:\/\/doi.org\/10.1007\/s10877-025-01307-w","DOI":"10.1007\/s10877-025-01307-w"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-025-01356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-025-01356-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-025-01356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:03:12Z","timestamp":1775455392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-025-01356-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s10877-025-01356-1","relation":{},"ISSN":["1573-2614"],"issn-type":[{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research group of M.I. has received (over the last 3\u00a0years) research grants from Becton Dickinson (Eysins, Switzerland) and consultancy fees from Aspen Healthcare FZ LLC (Dubai, UAE). M.I. serves as associate editor of the Journal of Clinical Monitoring and Computing The research group\/department of M.M.R.F.S. received (over the last 3\u00a0years) research grants and consultancy fees from Masimo (Irvine, CA, USA), Becton Dickinson (Eysins, Switzerland), Fresenius-Kabi (Bad Homburg, Germany), Paion (Aachen, Germany), Medcaptain Europe (Andelst, The Netherlands), Baxter (Chicago, IL, USA), and HanaPharm (Seoul, Republic of Korea). He receives royalties on intellectual property from Demed Medical (Sinaai, Belgium) and the Ghent University (Gent, Belgium)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}